Anne Taams, MSc

Assessor and researcher
Dutch Medicines Evaluation Board, Netherlands

Anne Taams was trained as a pharmaceutical scientist with specialisation in drug regulatory processes at Utrecht University. During her Master studies, she conducted research in Singapore for the Health Sciences Authority and the Medicines Evaluation Board (MEB). She joined the MEB as pharmacovigilance assessor in 2020. Anne continued her assessment work for fifty percent of the time. In addition, she focusses on the PhD project "mapping and managing uncertainties of innovative medicines" at the Division of Pharmacoepidemiology & Clinical Pharmacology of the Utrecht Institute for Pharmaceutical Sciences (UIPS), at Utrecht University. For more information or collaboration on this topic, please contact Anne via science@cbg-meb.nl

Disclosure information not submitted.

Presentation(s):

• The nature of uncertainties on the benefit-risk balance of anticancer medicines at initial marketing authorisation in the European Union

  Monday, August 26, 2024
  2:30 PM – 2:45 PM CEST